Navigation Links
New Prostate Cancer Biomarker Discovered
Date:6/18/2009

Finding also might apply in other types of cancer, researcher says

THURSDAY, June 18 (HealthDay News) -- A new marker for advanced prostate cancer and metastasis, or spread, of the disease has been identified by U.S. researchers.

Their analysis of prostate tissue from men with localized prostate cancer revealed that the men had significantly decreased levels of a stromal protein called caveolin-1. The researchers also found that the protein was not present in tumor tissue from men with metastatic prostate cancer.

Lower levels of caveolin-1 were associated with a high Gleason score, which is one of the most important predictors of poor clinical outcome among prostate cancer patients, according to the study, which appears online in advance of publication in the August print issue of Cell Cycle.

"We previously showed that the absence of stromal caveolin-1 is also associated with advanced tumor stage, early recurrence and metastasis of breast cancer," Dr. Michael Lisanti, a professor in the departments of cancer biology, medical oncology, and biochemistry and molecular biology at Jefferson Medical College at Thomas Jefferson University in Philadelphia, said in a university news release.

"Now we have identified [the protein's] similar prognostic value in prostate cancer," Lisanti added. "It is possible that this biomarker may be universal and could be widely applicable as a prognostic indicator for other cancer types as well."

More information

The American Cancer Society has more about prostate cancer.



-- Robert Preidt



SOURCE: Thomas Jefferson University, news release, June 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Organization Announces End Prostate Cancer Tour
2. Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital
3. Dad Offers Personal Father's Day Message on Importance of Prostate Cancer Screenings
4. Consumer Reports Best Buy Drug for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year
5. New approach for treating recurrent prostate cancer on the horizon
6. Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem
7. Decision tool for prostate cancer patients helps men customize treatment in anxious time
8. Kimberly-Clark Teams Up With Sports Legends to Launch The Depend Campaign to End Prostate Cancer
9. Prostate cancer test improves prediction of disease course
10. Longer Hormone Treatment May Improve Prostate Cancer Outlook
11. Hormone therapy may confer more aggressive properties to prostate tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Prostate Cancer Biomarker Discovered
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: